HER2低表达乳腺癌的临床特征和治疗方向
Linlin Zhou1, Yinghui Zhang1, Jiayu Zhang1
1Department of Breast Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Frontiers in oncology
|March 14, 2025
概括
人类表皮生长因子受体2 (HER2) 低表达乳腺癌是一种独特的亚型. 抗体-药物合物显示出治疗这种以前难以向的癌症的希望.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 人类表皮生长因子受体2 (HER2) 是乳腺癌的关键驱动因素,指导向治疗.
- HER2的表达有所变化,导致零,低和高表达的分类.
- 低表达HER2的乳腺癌对标准的抗HER2治疗不敏感,预后较差.
研究的目的:
- 审查HER2低表达乳腺癌的临床特征.
- 总结一下HER2低表达乳腺癌的近期治疗进展.
主要方法:
- 对HER2低表达性乳腺癌的临床特征和治疗剂的文献综述.
- 对这种患者群体中抗体-药物合物 (ADC) 的当前研究进行分析.
主要成果:
- 低HER2表达代表了乳腺癌管理中的独特临床挑战.
- 新出现的证据表明,抗体药物合物 (ADC) 对HER2低表达乳腺癌患者提供潜在的治疗益处.
- 目前正在进行的临床试验正在评估这种特定亚型的各种ADC疗法.
结论:
- HER2低表达性乳腺癌需要专门的治疗策略.
- 抗体药物合物正在成为HER2低表达乳腺癌患者的有希望的治疗途径,改善治疗选择和预后.
更多相关视频
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
2.5K
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.1K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
